Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MeridianLink | MLNK | Nov 26, 2024 | 23.19 | +0.83 |
Merit Medical Systems | MMSI | Nov 26, 2024 | 104.00 | -0.88 |
Meritage Homes | MTH | Nov 26, 2024 | 191.62 | -2.16 |
Merrill Lynch & Co. | IPB | Nov 26, 2024 | 25.71 | 0.00 |
Mersana Therapeutics | MRSN | Nov 26, 2024 | 2.17 | +8.50 |
Merus N.V | MRUS | Nov 26, 2024 | 45.87 | +1.06 |
Mesa Air Group | MESA | Nov 26, 2024 | 1.02 | +4.36 |
Mesa Laboratories | MLAB | Nov 26, 2024 | 116.45 | +2.49 |
Mesa Royalty Trust | MTR | Nov 26, 2024 | 7.12 | -1.11 |
Mesabi Royalty Trust | MSB | Nov 26, 2024 | 26.97 | +4.62 |
Mesoblast ADR | MESO | Nov 26, 2024 | 11.05 | +0.18 |
Meta Materials | MMAT | Nov 26, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 26, 2024 | 573.54 | +1.49 |
Metagenomi | MGX | Nov 26, 2024 | 2.01 | 0.00 |
Metal Sky Star Acquisition | MSSA | Nov 26, 2024 | 11.67 | 0.00 |
Metalla Royalty & Streaming | MTA | Nov 26, 2024 | 2.98 | -1.97 |
Metallus | MTUS | Nov 26, 2024 | 15.95 | -1.42 |
Metals Acquisition | MTAL | Nov 26, 2024 | 12.32 | -1.44 |
Methalpa Technology Holding | MATH | Nov 26, 2024 | 0.90 | -3.16 |
Methanex | MEOH | Nov 26, 2024 | 46.29 | -1.32 |
Methode Electronics | MEI | Nov 26, 2024 | 10.73 | +0.37 |
MetLife | MET | Nov 26, 2024 | 87.76 | +0.48 |
Metlife Pref A | MET-A | Nov 26, 2024 | 24.57 | +0.16 |
Metlife Pref E | MET-E | Nov 26, 2024 | 24.25 | -0.51 |
Metlife Pref F | MET-F | Nov 26, 2024 | 21.11 | -1.03 |
MetroCity Bankshares | MCBS | Nov 26, 2024 | 34.31 | -2.72 |
Metropolitan Bank | MCB | Nov 26, 2024 | 66.26 | -1.55 |
Mettler-Toledo International | MTD | Nov 26, 2024 | 1 232.30 | +0.64 |
Mexco Energy | MXC | Nov 26, 2024 | 12.09 | +0.96 |
Mexico Equity And Income Fund | MXE | Nov 26, 2024 | 8.28 | -1.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.